Anti-HER2 antibodies and their uses
US8937159B2 · kind B2 · utility
6Cited by
8References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2010 |
| Grant date | Jan 20, 2015 |
| Priority date | — |
| Expiry date | Nov 16, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure relates to antibodies directed to HER2 and uses of such antibodies, for example to treat diseases associated with the activity and/or overproduction of HER2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.